Literature DB >> 8895516

A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma.

J M Bosher1, N F Totty, J J Hsuan, T Williams, H C Hurst.   

Abstract

The proto-oncogene c-erbB-2 is overexpressed in 25-30% of breast cancers through increased transcription and amplification of the gene. We have previously described a factor, OB2-1 which upregulates c-erbB-2 transcription and which is closely related to the developmentally regulated transcription factor, AP-2. Further analysis of affinity purified OB2-1 has now shown that it is in fact a combination of proteins from three AP-2-related genes, the previously described AP-2alpha gene and two new human family members, AP-2beta and AP-2gamma whose cloning and characterisation are described here. All three AP-2 proteins show a high degree of homology and are capable of binding to the c-erbB-2 promoter as homo- or heterodimers. The three proteins can also activate a c-erbB-2 reporter construct, but AP-2alpha and AP-2gamma are 3-4 times more active in this regard than AP-2beta. In addition both AP-2alpha and AP-2gamma are expressed at elevated levels in the majority of c-erbB-2 overexpressing mammary tumour lines examined. Mechanisms which may have led to the increased AP-2 levels in these cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895516

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  61 in total

Review 1.  Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland.

Authors:  N P Bates; H C Hurst
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

2.  A new mutator phenotype in breast cancer?

Authors:  Johan G de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

3.  Characterization of the 12C4 survivin monoclonal antibody and insight into the expression of survivin in human adult tissues.

Authors:  B Spaulding; D Pan; A Ghadersohi; G Nielsen; S Jensen; F Gellert; X Ling; M Zhang; A Black; F Li
Journal:  Histopathology       Date:  2006-12       Impact factor: 5.087

4.  Redundant activities of Tfap2a and Tfap2c are required for neural crest induction and development of other non-neural ectoderm derivatives in zebrafish embryos.

Authors:  Wei Li; Robert A Cornell
Journal:  Dev Biol       Date:  2006-12-23       Impact factor: 3.582

5.  Chromatin modifications sequentially enhance ErbB2 expression in ErbB2-positive breast cancers.

Authors:  Sathish Kumar Mungamuri; William Murk; Luca Grumolato; Emily Bernstein; Stuart A Aaronson
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

6.  Characterization of the human activator protein-2gamma (AP-2gamma) gene: control of expression by Sp1/Sp3 in breast tumour cells.

Authors:  Mark D Hasleton; J Claire Ibbitt; Helen C Hurst
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

7.  Diversity and complexity in DNA recognition by transcription factors.

Authors:  Gwenael Badis; Michael F Berger; Anthony A Philippakis; Shaheynoor Talukder; Andrew R Gehrke; Savina A Jaeger; Esther T Chan; Genita Metzler; Anastasia Vedenko; Xiaoyu Chen; Hanna Kuznetsov; Chi-Fong Wang; David Coburn; Daniel E Newburger; Quaid Morris; Timothy R Hughes; Martha L Bulyk
Journal:  Science       Date:  2009-05-14       Impact factor: 47.728

8.  Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes.

Authors:  Francesca Orso; Davide Corà; Benedetta Ubezio; Paolo Provero; Michele Caselle; Daniela Taverna
Journal:  BMC Genomics       Date:  2010-06-03       Impact factor: 3.969

9.  AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma.

Authors:  Kristi L Bennett; Todd Romigh; Charis Eng
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

10.  Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.

Authors:  Grégory Nolens; Jean-Christophe Pignon; Benjamin Koopmansch; Benaïssa Elmoualij; Willy Zorzi; Edwin De Pauw; Rosita Winkler
Journal:  Breast Cancer Res       Date:  2009-11-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.